IRIS

Sfoglia per Autore  

Opzioni
Mostrati risultati da 21 a 40 di 119
Titolo Tipologia Data di pubblicazione Autore(i) File
Isolation of Two Novel Human Anti-CTLA-4 mAbs with Intriguing Biological Properties on Tumor and NK Cells 1.1 Articolo in rivista 2020 Passariello, M; Vetrei, C; Sasso, E; Froechlich, G; Gentile, C; D'Alise, Am; Zambrano, N; Scarselli, E; Nicosia, A; De Lorenzo, C.
Aptamer targeted therapy potentiates immune checkpoint blockade in triple-negative breast cancer 1.1 Articolo in rivista 2020 Camorani, Simona; Passariello, Margherita; Agnello, Lisa; Esposito, Silvia; Collina, Francesca; Cantile, Monica; Di Bonito, Maurizio; Ulasov, Ilya V; Fedele, Monica; Zannetti, Antonella; De Lorenzo, Claudia; Cerchia, Laura
T-cell Activating Tribodies as a Novel Approach for Efficient Killing of ErbB2-positive Cancer Cells. 1.1 Articolo in rivista 2019 Riccio, G; Ricardo, Ar; Passariello, M; Saraiva, K; Rubino, V; Cunnah, P; Mertens, N; De Lorenzo, C.
Cardiotoxicity and pro-inflammatory effects of the immune checkpoint inhibitor Pembrolizumab associated to Trastuzumab 1.1 Articolo in rivista 2019 Quagliariello, V; Passariello, Margherita; Coppola, C; Rea, D. d.; Barbieri, A.; Scherillo, M.; Monti, M. G.; Iaffaioli, R. V.; Laurentiis, De; Ascierto, Pa.; Botti, G.; De Lorenzo, Claudia.; Maurea, N.
Novel Human Anti-PD-L1 mAbs Inhibit Immune-Independent Tumor Cell Growth and PD-L1 Associated Intracellular Signalling 1.1 Articolo in rivista 2019 Passariello, M; D'Alise, Am; Esposito, A; Vetrei, C; Froechlich, Guendalina; Scarselli, E; Nicosia, A; De Lorenzo, C.
Novel Human Bispecific Aptamer-Antibody Conjugates for Efficient Cancer Cell Killing 1.1 Articolo in rivista 2019 Passariello, M; Camorani, S; Vetrei, Cinzia; Cerchia, L; De Lorenzo, C.
Rapid Affinity Maturation of Novel Anti-PD-L1 Antibodies by a Fast Drop of the Antigen Concentration and FACS Selection of Yeast Libraries 1.1 Articolo in rivista 2019 Cembrola, B; Ruzza, V; Troise, F; Esposito, Ml; Sasso, E; Cafaro, V; Passariello, M; Visconte, F; Raia, M; Del Vecchio, L; D'Alise, Am; Cortese, R; Scarselli, E; Zambrano, N; De Lorenzo, C; Nicosia, A
Massive parallel screening of phage libraries for the generation of repertoires of human immunomodulatory monoclonal antibodies. 1.1 Articolo in rivista 2018 Sasso, E; D'Avino, C; Passariello, M; D'Alise, Am; Siciliano, D; Esposito, Ml; Froechlich, Guendalina; Cortese, R; Scarselli, E; Zambrano, N; Nicosia, A; De Lorenzo, C.
Cardiotoxic effects of the novel approved anti-ErbB2 agents and reverse cardioprotective effects of Ranolazine 1.1 Articolo in rivista 2018 DE LORENZO, Claudia; Paciello, Rolando; Riccio, Gennaro; Rea, Domenica; Barbieri, Antonio; Coppola, Carmela; Maurea, Nicola
A long non-coding SINEUP RNA boosts semi-stable production of fully human monoclonal antibodies in HEK293E cells 1.1 Articolo in rivista 2018 Sasso, Emanuele; Latino, Debora; Froechlich, Guendalina; Succoio, Mariangela; Passariello, Margherita; De Lorenzo, Claudia; Nicosia, Alfredo; Zambrano, Nicola
Ranolazine attenuates trastuzumab-induced heart dysfunction by modulating ROS production 1.1 Articolo in rivista 2018 Riccio, Gennaro; Antonucci, Salvatore; Coppola, Carmela; D'Avino, Chiara; Piscopo, Giovanna; Fiore, Danilo; Maurea, Carlo; Russo, Michele; Rea, Domenica; Arra, Claudio; Condorelli, Gerolama; Di Lisa, Fabio; Tocchetti, Carlo G.; De Lorenzo, Claudia; Maurea, Nicola
Methods and compositions relating to Anti-nucleolin recombinant immunoagents 6.1 Brevetto 2017 DE LORENZO, Claudia; Palmieri, Dario; Croce, Carlo
Superior Suppression of ErbB2-positive Tumor Cells by a Novel Human Triparatopic Tribody 1.1 Articolo in rivista 2017 Riccio, Gennaro; Da Fonseca Ricardo, Ana R; Passariello, Margherita; Cunnah, Philip; Mertens, Nico; DE LORENZO, Claudia
Fusion protein comprising three binding domains to HER2 6.1 Brevetto 2016 DE LORENZO, Claudia; Riccio, Gennaro; Mertens, Nico; FONSECA RICARDO ANA RITA, Da; Jeffrey, CUNNAH PHILIP; NORHONA PISSARRA, Pedro
Novel human anti-Claudin 1 monoclonal antibodies inhibit HCV infection and may synergize with anti-SRB1 mAb. 1.1 Articolo in rivista 2016 Paciello, Rolando; Urbanowicz, Ra; Riccio, G; Sasso, Emanuele; Mcclure, Pc; Zambrano, Nicola; Ball, Jk; Cortese, R; Nicosia, Alfredo; DE LORENZO, Claudia
Antineoplastic-related cardiotoxicity, morphofunctional aspects in a murine model: contribution of the new tool 2D-speckle tracking 1.1 Articolo in rivista 2016 Carmela, Coppola; Gennaro, Riccio; Antonio, Barbieri; Monti, MARIA GAIA; Giovanna, Piscopo; Domenica, Rea; Claudio, Arra; Carlo, Maurea; DE LORENZO, Claudia; Nicola, Maurea
RANOLAZINE AT THE END OF TRASTUZUMAB THERAPY PREVENTS LEFT VENTRICULAR DYSFUNCTION: IN VITRO AND IN VIVO STUDY 1.5 Abstract in rivista 2016 Maurea, N; Coppola, C; Piscopo, G; Rea, D; Riccio, Gennaro; Condorelli, Gerolama; Arra, C; DE LORENZO, Claudia
Trastuzumab and target-therapy side effects: Is still valid to differentiate anthracycline Type I from Type II cardiomyopathies? 1.1 Articolo in rivista 2016 Riccio, Gennaro; Coppola, C; Piscopo, G; Capasso, I; Maurea, C; Esposito, E; DE LORENZO, Claudia; Maurea, N.
A novel fully human anti-NCL immunoRNase for triple-negative breast cancer therapy 1.1 Articolo in rivista 2016 D'Avino, Chiara; Palmieri, Dario; Braddom, Ashley; Zanesi, Nicola; James, Cindy; Cole, Sara; Salvatore, Francesco; Croce, Carlo M.; DE LORENZO, Claudia
Pathophysiology of cardiotoxicity from target therapy and angiogenesis inhibitors 1.1 Articolo in rivista 2016 Maurea, Nicola; Coppola, Carmela; Piscopo, Giovanna; Galletta, Francesca; Riccio, Gennaro; Esposito, Emanuela; DE LORENZO, Claudia; DE LAURENTIIS, Michelino; Spallarossa, Paolo; Mercuro, Giuseppe
Mostrati risultati da 21 a 40 di 119
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile